BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 27417710)

  • 1. Glutamate release and uptake processes are altered in a new mouse model of amyotrophic lateral sclerosis.
    Grigoriev VV; Efimova AD; Ustyugov AA; Shevchenko VP; Bachurin SO; Myasoedov NF
    Dokl Biochem Biophys; 2016 May; 468(1):165-7. PubMed ID: 27417710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal exocytotic release of glutamate in a mouse model of amyotrophic lateral sclerosis.
    Milanese M; Zappettini S; Onofri F; Musazzi L; Tardito D; Bonifacino T; Messa M; Racagni G; Usai C; Benfenati F; Popoli M; Bonanno G
    J Neurochem; 2011 Mar; 116(6):1028-42. PubMed ID: 21175617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glutamate release induced by activation of glycine and GABA transporters in spinal cord is enhanced in a mouse model of amyotrophic lateral sclerosis.
    Raiteri L; Zappettini S; Stigliani S; Paluzzi S; Raiteri M; Bonanno G
    Neurotoxicology; 2005 Oct; 26(5):883-92. PubMed ID: 15885796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A mice model of amyotrophic lateral sclerosis expressing mutant human FUS protein].
    Deĭkin AV; Kovrazhkina EA; Ovchinnikov RK; Bronovitskiĭ EV; Razinskaia OD; Smirnov AP; Ermolkevich TG; Eliakov AB; Popov AN; Fedorov EN; Lytkina OA; Kukharskiĭ MS; Tarasova TV; Shelkovnikova TA; Ustiugov AA; Ninkina NN; Gol'dman IL; Sadchikova ER; Bachurin SO; Skvortsova VI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(8):62-9. PubMed ID: 25345633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exocytosis regulates trafficking of GABA and glycine heterotransporters in spinal cord glutamatergic synapses: a mechanism for the excessive heterotransporter-induced release of glutamate in experimental amyotrophic lateral sclerosis.
    Milanese M; Bonifacino T; Fedele E; Rebosio C; Cattaneo L; Benfenati F; Usai C; Bonanno G
    Neurobiol Dis; 2015 Feb; 74():314-24. PubMed ID: 25497732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
    Milanese M; Giribaldi F; Melone M; Bonifacino T; Musante I; Carminati E; Rossi PI; Vergani L; Voci A; Conti F; Puliti A; Bonanno G
    Neurobiol Dis; 2014 Apr; 64():48-59. PubMed ID: 24361555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Excessive and precocious glutamate release in a mouse model of amyotrophic lateral sclerosis.
    Raiteri L; Stigliani S; Zappettini S; Mercuri NB; Raiteri M; Bonanno G
    Neuropharmacology; 2004 May; 46(6):782-92. PubMed ID: 15033338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of a glycine transporter on spinal cord neurons causes enhanced glutamate release in a mouse model of amyotrophic lateral sclerosis.
    Raiteri L; Paolucci E; Prisco S; Raiteri M; Bonanno G
    Br J Pharmacol; 2003 Mar; 138(6):1021-5. PubMed ID: 12684256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Group I metabotropic glutamate autoreceptors induce abnormal glutamate exocytosis in a mouse model of amyotrophic lateral sclerosis.
    Giribaldi F; Milanese M; Bonifacino T; Anna Rossi PI; Di Prisco S; Pittaluga A; Tacchetti C; Puliti A; Usai C; Bonanno G
    Neuropharmacology; 2013 Mar; 66():253-63. PubMed ID: 22634363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered astrocytic response to activation in SOD1(G93A) mice and its implications on amyotrophic lateral sclerosis pathogenesis.
    Benkler C; Ben-Zur T; Barhum Y; Offen D
    Glia; 2013 Mar; 61(3):312-26. PubMed ID: 23280929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased internalisation and degradation of GLT-1 glial glutamate transporter in a cell model for familial amyotrophic lateral sclerosis (ALS).
    Vanoni C; Massari S; Losa M; Carrega P; Perego C; Conforti L; Pietrini G
    J Cell Sci; 2004 Oct; 117(Pt 22):5417-26. PubMed ID: 15466883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. System xC- is a mediator of microglial function and its deletion slows symptoms in amyotrophic lateral sclerosis mice.
    Mesci P; Zaïdi S; Lobsiger CS; Millecamps S; Escartin C; Seilhean D; Sato H; Mallat M; Boillée S
    Brain; 2015 Jan; 138(Pt 1):53-68. PubMed ID: 25384799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GLT1 overexpression in SOD1(G93A) mouse cervical spinal cord does not preserve diaphragm function or extend disease.
    Li K; Hala TJ; Seetharam S; Poulsen DJ; Wright MC; Lepore AC
    Neurobiol Dis; 2015 Jun; 78():12-23. PubMed ID: 25818008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased expression of the glial glutamate transporter EAAT2 modulates excitotoxicity and delays the onset but not the outcome of ALS in mice.
    Guo H; Lai L; Butchbach ME; Stockinger MP; Shan X; Bishop GA; Lin CL
    Hum Mol Genet; 2003 Oct; 12(19):2519-32. PubMed ID: 12915461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis.
    Rothstein JD; Martin LJ; Kuncl RW
    N Engl J Med; 1992 May; 326(22):1464-8. PubMed ID: 1349424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early and selective reduction of NOP56 (Asidan) and RNA processing proteins in the motor neuron of ALS model mice.
    Miyazaki K; Yamashita T; Morimoto N; Sato K; Mimoto T; Kurata T; Ikeda Y; Abe K
    Neurol Res; 2013 Sep; 35(7):744-54. PubMed ID: 23582672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebral neurons of transgenic ALS mice are vulnerable to glutamate release stimulation but not to increased extracellular glutamate due to transport blockade.
    Tovar-y-Romo LB; Tapia R
    Exp Neurol; 2006 Jun; 199(2):281-90. PubMed ID: 16364298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotonergic mechanisms in amyotrophic lateral sclerosis.
    Sandyk R
    Int J Neurosci; 2006 Jul; 116(7):775-826. PubMed ID: 16861147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glutamate and glutathione interplay in a motor neuronal model of amyotrophic lateral sclerosis reveals altered energy metabolism.
    D'Alessandro G; Calcagno E; Tartari S; Rizzardini M; Invernizzi RW; Cantoni L
    Neurobiol Dis; 2011 Aug; 43(2):346-55. PubMed ID: 21530659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stepwise acquirement of hallmark neuropathology in FUS-ALS iPSC models depends on mutation type and neuronal aging.
    Japtok J; Lojewski X; Naumann M; Klingenstein M; Reinhardt P; Sterneckert J; Putz S; Demestre M; Boeckers TM; Ludolph AC; Liebau S; Storch A; Hermann A
    Neurobiol Dis; 2015 Oct; 82():420-429. PubMed ID: 26253605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.